Iakoubov R - Search Results

1

Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.

Kühnen P, Matthae R, Arya V, Hauptmann K, Rothe K, Wächter S, Singer M, Mohnike W, Eberhard T, Raile K, Lauffer LM, Iakoubov R, Hussain K, Blankenstein O. Kühnen P, et al. Among authors: iakoubov r. Clin Endocrinol (Oxf). 2014 Dec;81(6):847-54. doi: 10.1111/cen.12473. Epub 2014 May 19. Clin Endocrinol (Oxf). 2014. PMID: 24750227

2

GPR119: "double-dipping" for better glycemic control.

Lauffer L, Iakoubov R, Brubaker PL. Lauffer L, et al. Among authors: iakoubov r. Endocrinology. 2008 May;149(5):2035-7. doi: 10.1210/en.2008-0182. Endocrinology. 2008. PMID: 18427153 No abstract available.

3

Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice.

Iakoubov R, Lauffer LM, Trivedi S, Kim YI, Brubaker PL. Iakoubov R, et al. Endocrinology. 2009 Sep;150(9):4033-43. doi: 10.1210/en.2009-0295. Epub 2009 Jun 4. Endocrinology. 2009. PMID: 19497974

4

Essential role for protein kinase Cζ in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat.

Iakoubov R, Ahmed A, Lauffer LM, Bazinet RP, Brubaker PL. Iakoubov R, et al. Endocrinology. 2011 Apr;152(4):1244-52. doi: 10.1210/en.2010-1352. Epub 2011 Feb 15. Endocrinology. 2011. PMID: 21325047

5

T1R3: how to indulge the gut's sweet tooth.

Iakoubov R, Lauffer LM. Iakoubov R, et al. Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E813-4. doi: 10.1152/ajpendo.00418.2012. Epub 2012 Aug 14. Am J Physiol Endocrinol Metab. 2012. PMID: 22895784 Free article. No abstract available.

6

Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.

Sangle GV, Lauffer LM, Grieco A, Trivedi S, Iakoubov R, Brubaker PL. Sangle GV, et al. Among authors: iakoubov r. Endocrinology. 2012 Feb;153(2):564-73. doi: 10.1210/en.2011-1732. Epub 2011 Dec 20. Endocrinology. 2012. PMID: 22186413

7

GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.

Lauffer LM, Iakoubov R, Brubaker PL. Lauffer LM, et al. Among authors: iakoubov r. Diabetes. 2009 May;58(5):1058-66. doi: 10.2337/db08-1237. Epub 2009 Feb 10. Diabetes. 2009. PMID: 19208912 Free PMC article.

8

Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells.

Iakoubov R, Izzo A, Yeung A, Whiteside CI, Brubaker PL. Iakoubov R, et al. Endocrinology. 2007 Mar;148(3):1089-98. doi: 10.1210/en.2006-1403. Epub 2006 Nov 16. Endocrinology. 2007. PMID: 17110421

9

Dynamics of Adrenocorticotropin after Application of Metyrapone.

Noe S, von Werder A, Iakoubov R, Schneider H, Thaler M, Luppa P, Neu B. Noe S, et al. Among authors: iakoubov r. Exp Clin Endocrinol Diabetes. 2017 Jan;125(1):53-56. doi: 10.1055/s-0042-117832. Epub 2016 Oct 17. Exp Clin Endocrinol Diabetes. 2017. PMID: 27750352

10

Clinically relevant lot-to-lot reagent difference in a commercial immunoturbidimetric assay for glycated hemoglobin A1c.

Thaler MA, Iakoubov R, Bietenbeck A, Luppa PB. Thaler MA, et al. Among authors: iakoubov r. Clin Biochem. 2015 Nov;48(16-17):1167-70. doi: 10.1016/j.clinbiochem.2015.07.018. Epub 2015 Jul 15. Clin Biochem. 2015. PMID: 26187005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page